Raymond James Financial Services Advisors, Inc. Ocular Therapeutix, Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 96,644 shares of OCUL stock, worth $877,527. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,644
Previous 72,751
32.84%
Holding current value
$877,527
Previous $497,000
69.01%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding OCUL
# of Institutions
171Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$131 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$116 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$116 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$76.1 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $699M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...